N@N

Biomoda Featured on Business Radio

^{Published on 2011-01-18 05:10:35 - Market Wire}
 

ALBUQUERQUE, N.M.--([ BUSINESS WIRE ])--Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) ([ www.biomoda.com ]) is the focus of a series of nationally syndicated business radio talk shows airing on the Business Talk Radio Network ([ www.businesstalkradio.net/ ]) and the Radio America Network ([ www.radioamerica.org ]), as well as Money Matters Radio ([ www.moneymattersradio.net ]) in the Boston market.

"One of our top priorities is to develop additional outlets to keep our shareholders and other interested parties up to date on company developments"

aOne of our top priorities is to develop additional outlets to keep our shareholders and other interested parties up to date on company developments,a Biomoda Chief Executive Officer Maria Zannes said. aThe radio broadcasts provide a great opportunity to talk about our CyPath® diagnostic assay for the detection of early-stage lung cancer and progress in our ongoing pilot clinical trial.a

In the January 2011 [ Presidenta™s Column ] (posted on [ www.biomoda.com ]), Zannes said the radio broadcasts make Biomoda more accessible. aI like radio because it allows the listener to get a better sense of the people behind the company -- what they think and how they reason.a

aEquity Strategies,a the nationally syndicated business broadcast, and aStu Taylor on Business,a a morning drive-time Boston broadcast, are anchored by business talk show host Stu Taylor.

Broadcasts featuring interviews with Biomoda President John Cousins are [ archived ] on the Biomoda [ website ]. Additional broadcasts will be archived after they air.

About Biomoda

Biomoda ([ www.biomoda.com ]) is a cancer diagnostics company focused on the development of accurate, inexpensive and noninvasive tests for the early detection of cancer. In addition to its first product for lung cancer, diagnostic assays for cervical, breast, colorectal, bladder and oral cancers are targeted for development.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on estimates, projections, beliefs and assumptions of Biomoda management at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements due to a variety of factors, which are described from time to time in the Companya™s reports and registration statements filed with the Securities and Exchange Commission, including those under the heading "Risk Factors" in the Company's Annual Report on Form 10-K filed with the SEC on March 30, 2010. Forward-looking statements are made as of the date of this press release and are subject to change without notice.